E-LIB Suche - Ergebnisse für: Loonen, A.J.M

1

P.0579 Pharmacogenetic study to elucidate putative dopamine..:

Ochi, T. ; Vyalova, N.M. ; Losenkov, I.S....
European Neuropsychopharmacology. 53 (2021) - p. S424-S425 , 2021

Link: https://doi.org/10.1016/..

2

Diagnose, indicate, and treat severe mental illness (DITSMI..:

Veereschild, H. M. ; Noorthoorn, E. O. ; Nijman, H. L. I....
European Psychiatry. 63 (2020) 1 - p. , 2020

Link: https://doi.org/10.1192/..

3

P.143 Population pharmacokinetic model and limited sampling..:

Geers, L.M. ; Cohen, D. ; Wehkamp, L.M....
European Neuropsychopharmacology. 40 (2020) - p. S88 , 2020

Link: https://doi.org/10.1016/..

4

P.541 Inflammation in schizophrenia with metabolic syndrome..:

Boiko, A.S. ; Kornetova, E.G. ; Loonen, A.J.M..
European Neuropsychopharmacology. 40 (2020) - p. S305-S306 , 2020

Link: https://doi.org/10.1016/..

5

P.583 Polymorphisms in BDNF, AKT1, GSK3B genes: possible as..:

Ivanova, S.A. ; Paderina, D.Z. ; Boiko, A.S....
European Neuropsychopharmacology. 40 (2020) - p. S331-S332 , 2020

Link: https://doi.org/10.1016/..

6

Apolipoprotein serum levels related to metabolic side effec..:

Ivanova, S.A. ; Boiko, A.S. ; Mednova, I.A...
European Neuropsychopharmacology. 29 (2019) - p. S115-S116 , 2019

Link: https://doi.org/10.1016/..

7

Tardive dyskinesia in schizophrenia: Gene polymorphisms of ..:

Boiko, A.S. ; Pozhidaev, I. ; Semke, A....
European Neuropsychopharmacology. 29 (2019) - p. S117-S118 , 2019

Link: https://doi.org/10.1016/..

8

P.505 The potential role of BDNF and prolactin genotypes on..:

Vyalova, N. ; Ochi, T. ; Losenkov, I....
European Neuropsychopharmacology. 29 (2019) - p. S355-S356 , 2019

Link: https://doi.org/10.1016/..

9

P.390 Characteristics of metabolic hormones in patients wit..:

Boiko, A.S. ; Kornetova, E.G. ; Mednova, I.A...
European Neuropsychopharmacology. 29 (2019) - p. S276-S277 , 2019

Link: https://doi.org/10.1016/..

10

P.374 Cortisol and DHEAS related to metabolic side effects ..:

Ivanova, S.A. ; Boiko, A.S. ; Mednova, I.A...
European Neuropsychopharmacology. 29 (2019) - p. S265-S266 , 2019

Link: https://doi.org/10.1016/..

11

Association of polymorphism in the dopamine receptors and t..:

Osmanova, D. ; Boiko, A.S. ; Fedorenko, O.Y....
European Neuropsychopharmacology. 27 (2017) - p. S923-S924 , 2017

Link: https://doi.org/10.1016/..

12

High pneumococcal DNA load, procalcitonin and suPAR levels ..:

Loonen, A. J. M. ; Kesarsing, C. ; Kusters, R....
European Journal of Clinical Microbiology & Infectious Diseases. 36 (2017) 9 - p. 1541-1547 , 2017

Link: https://doi.org/10.1007/..

13

Predictive genetic model for levodopa-induced dyskinesia in..:

Ivanova, S.A. ; Alifirova, V.M. ; Freidin, M.B....
European Neuropsychopharmacology. 27 (2017) - p. S1039-S1040 , 2017

Link: https://doi.org/10.1016/..

14

Potential biomarkers of tardive dyskinesia: a multiplex ana..:

Boiko, A.S. ; Kornetova, E.G. ; Ivanova, S.A..
European Neuropsychopharmacology. 27 (2017) - p. S945-S946 , 2017

Link: https://doi.org/10.1016/..

15

Association between P-glycoprotein polymorphisms and antips..:

Geers, L.M. ; Pozhidaev, I.V. ; Ivanova, S.A....
European Neuropsychopharmacology. 27 (2017) - p. S956 , 2017

Link: https://doi.org/10.1016/..